The Louisiana Academy of Family Physicians cordially invites you to attend a CME/CE-certified presentation titled, “Managing Elevated LDL-C Levels to Reduce ASCVD Risk: Primary and Secondary Prevention.” This activity will provide primary care providers with the necessary knowledge to identify and treat patients who would benefit from ASCVD risk reduction. Learn about the latest treatment recommendations, including nonstatin therapies, LDL-C goals, and best practices in developing a personalized multidisciplinary treatment plan to optimize patient care.
Date: Thursday, June 27, 2023
Time: 7:00 PM – 8:00 PM CENTRAL
Location: Live Online
Learning Objectives:
- Assess the efficacy, safety, and mechanism of action of nonstatin agents approved to manage LDL-C levels
- Devise individualized evidence-based primary prevention plans for patients with elevated LDL-C levels
- Develop personalized strategies for secondary prevention for patients with elevated LDL-C levels using evidence-based guidelines
- Escalate treatment of elevated LDL-C levels by incorporating approved nonstatin agents when statins alone do not achieve 2018 blood cholesterol guideline goals
Program Faculty
 |
 |
|
Ty J. Gluckman, MD, MHA,
FACC, FAHA, FASPC |
Erin D. Michos, MD, MHS, FACC, FAHA, FASE, FASPC |
Registration
Attendance is free, but registration is required. Register Today!
Suggested Browsers: Apple Safari, Google Chrome, or Mozilla Firefox
CME Accreditation
ACCREDITATION STATEMENT: This activity has been planned and implemented in according with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of USF Health and Rockpointe. USF Health is accredited by the ACCME to provide continuing medical education for physicians.
PHYSICIAN CREDIT DESIGNATION STATEMENT: USF Health designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
AAFP CREDIT DESIGNATION STATEMENT The AAFP has reviewed Managing Elevated LDL-C Levels to Reduce ASCVD Risk: Primary and Secondary Prevention, and deemed it acceptable for AAFP credit. Term of approval is from 04/04/2023 to 08/01/2023. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Still have questions…… contact the LAFP at 225.923.3313.
